for women and men with busy daily routines who find dieting hard
60-day money back guarantee
What it does?
SWITCHES OFF HUNGER
MAKES YOU FEEL FULL FASTER
FULLNESS LASTS FOR DAYS, NOT HOURS
BOOSTS YOUR METABOLISM, FAT BURNS ON ITS OWN
DEVELOPS AN AVERSION TO JUNK FOOD AND ALCOHOL
WORKS AT YOUR DESK, IN YOUR CAR, AND WHILE YOU SLEEP
SEE IT FOR YOURSELF
01
What it is
Inside is retatrutide, a peptide built of 39 amino acids, the same building blocks that every protein in your body and your food is made from. In other words, it's a concentrated set of the individual parts of a protein.
02
How you use it
It comes as a pre-filled, ready-to-use pen. One click, once a week. One pen = up to 8 weekly doses = 2 months.
03
The result
Less hunger, steady fat loss. Up to 24% body weight.
P.S. Physical activity can slightly speed up the process and strengthen your final results.
01
What it is
Inside is retatrutide, a peptide built of 39 amino acids, the same building blocks that every protein in your body and your food is made from. In other words, it's a concentrated set of the individual parts of a protein.
02
How you use it
It comes as a pre-filled, ready-to-use pen. One click, once a week. One pen = up to 8 weekly doses = 2 months.
03
The result
Less hunger, steady fat loss. Up to 24% body weight.
P.S. Physical activity can slightly speed up the process and strengthen your final results.
Buy retatrutide EU - retatrutide pen online by NEXA
Buy NEXA Retatrutide - Triple-Action Weight Loss
Buy NEXA Retatrutide from NEXA for clinically advanced triple-action weight loss results. NEXA Retatrutide contains Retatrutide (LY3437943) - Eli Lilly's first-in-class GIP, GLP-1, and Glucagon triple hormone receptor agonist - in a verified, pharmaceutical-grade formulation. Every NEXA Retatrutide pen is HPLC-verified at 99.7% purity with a full Certificate of Analysis on every batch.
According to the TRIUMPH-1 Phase 3 trial resultspublished by Eli Lilly in May 2026, Retatrutide at the 12mg maintenance dose produced an average of 28.3% body weight reduction over 80 weeks. Forty-five percent of participants achieved 30% or more weight loss - a result previously associated only with bariatric surgery. The NHS healthy weight guidancerecommends a medically supported weight management approach, and NEXA Retatrutide delivers the most powerful pharmacological tool available in that framework.
What is NEXA Retatrutide and how does it work?
NEXA Retatrutide weight loss results are produced by a triple hormonal mechanism that surpasses every other injectable weight loss medication currently available. GLP-1 receptor activation reduces appetite and slows gastric emptying. GIP receptor activation enhances fat metabolism and amplifies satiety signals beyond what single-receptor medications achieve. Glucagon receptor activation increases energy expenditure by stimulating direct fat burning in the liver - a mechanism entirely absent from single and dual receptor medications like Ozempic and Mounjaro.
By activating all three pathways simultaneously, NEXA Retatrutide creates a more powerful and sustained metabolic shift than any other medication in its class. Results from the TRIUMPH-1 Phase 3 trial show participants on 9mg losing an average of 23.7% of body weight, and those on 12mg losing 25% at 80 weeks overall - with the subgroup of participants escalated to maximum tolerated dose achieving the full 28.3% NEXA Retatrutide weight loss result. These figures represent a new benchmark in non-surgical obesity treatment and position NEXA Retatrutide above Mounjaro, Ozempic, Wegovy, and CagriReta in head-to-head clinical comparisons.
Who can use NEXA Retatrutide for weight loss?
NEXA Retatrutide is suitable for adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition such as high blood pressure, elevated cholesterol, or type 2 diabetes. It is particularly well-suited for patients who have achieved good but insufficient results on Mounjaro or CagriReta and are seeking the next level of NEXA Retatrutide weight loss results. It is not suitable for those with a personal or family history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or those who are pregnant or planning pregnancy. Contact our 24/7 support team before ordering if you are unsure whether NEXA Retatrutide is the right choice for your weight loss journey.
How to calculate your NEXA Retatrutide dosage
NEXA Retatrutide is administered as a once-weekly subcutaneous injection following this escalation schedule for the NEXA 4 × 10 mg pen:
Weeks 1-4: 5 mg once weekly (starting dose).
Week 5 onward: 10 mg once weekly (maintenance).
On the starting dose, your first pen lasts up to 8 weeks.
Never increase faster than your prescribed schedule. If side effects occur at any stage, stay at your current dose and contact our support team before making any changes.
How to use NEXA Retatrutide injections
Always read the package leaflet and follow your doctor's instructions. Inject at the same time every week on the same day for the best NEXA Retatrutide weight loss results.
Choose your injection site - the abdomen, upper thigh, or upper arm. Wash your hands thoroughly with soap and water. Inspect the pen - check the expiry date, confirm no damage, and verify the liquid is clear and colourless. Attach a new sterile needle and never reuse a needle between injections. Prime the pen upward to remove air bubbles. Set the dose to your prescribed amount. Insert the needle, press the dose button, and hold for six seconds. Withdraw and confirm the dose counter shows zero. Remove the needle safely and replace the pen cap.
Why buy NEXA Retatrutide from NEXA?
When you buy NEXA Retatrutide from NEXA you receive a fully verified, transparently sourced product backed by our 24/7 support team. Every batch is independently tested and the Certificate of Analysis ships with every order so you can verify exactly what you receive.
